Evidence map›Paper›PMID 40980675›Full record

ArticleKidney international reports2025

A Within-Trial Economic Evaluation of a Patient Navigator Program in Children With CKD.

Winnie Chen, Germaine Wong, Kirsten Howard, Chandana Guha, Anita van Zwieten, Andrea N Natsky, Kylie-Ann Mallitt, Rabia Khalid, Anna Francis, Allison Jaure and 20 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Kidney international reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Implementing Patient Navigation for Children With CKD.Kidney international reports · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

30 authors.

Winnie ChenLeeder Centre for Health Policy, Economics and Data, Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia.
Germaine WongSchool of Public Health, University of Sydney, Sydney, New South Wales, Australia.
Kirsten HowardLeeder Centre for Health Policy, Economics and Data, Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia.
Chandana GuhaSchool of Public Health, University of Sydney, Sydney, New South Wales, Australia.
Anita van ZwietenSchool of Public Health, University of Sydney, Sydney, New South Wales, Australia.
Andrea N NatskyLeeder Centre for Health Policy, Economics and Data, Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia.
Kylie-Ann MallittSchool of Public Health, University of Sydney, Sydney, New South Wales, Australia.
Rabia KhalidChildren's Hospital Westmead Clinical School, The University of Sydney, Westmead, New South Wales, Australia.
Anna FrancisQueensland Child and Adolescent Renal Service, Queensland Children's Hospital, Queensland, Australia.
Allison JaureSchool of Public Health, University of Sydney, Sydney, New South Wales, Australia.
Siah KimSchool of Public Health, University of Sydney, Sydney, New South Wales, Australia.
Armando Teixeira-PintoSchool of Public Health, University of Sydney, Sydney, New South Wales, Australia.
Amelie Bernier-JeanCanada and CIUSSS du Nord-de-l'Île-de-Montréal, University of Montreal, Montreal, Quebec, Canada.
David W JohnsonAustralasian Kidney Trials Network, University of Queensland, Brisbane, Queensland, Australia.
Deirdre HahnCentre for Kidney Research, Children's Hospital at Westmead, Sydney, New South Wales, Australia.
Elizabeth G RyanSchool of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.
Hugh J McCarthyCentre for Kidney Research, Children's Hospital at Westmead, Sydney, New South Wales, Australia.
Charani KiriwandeniyaAustralasian Kidney Trials Network, University of Queensland, Brisbane, Queensland, Australia.
Nicholas LarkinsDepartment of Nephrology, Perth Children's Hospital, Perth, Western Australia, Australia.
Patrina CaldwellCentre for Kidney Research, Children's Hospital at Westmead, Sydney, New South Wales, Australia.
Reginald WoodleighProstate and Breast Cancer Foundation (CanCare), Sydney, New South Wales, Australia.
Simon A CarterDepartment of Nephrology, The Royal Children's Hospital Melbourne, Melbourne, Victoria, Australia.
Sean E KennedyDepartment of Nephrology, Sydney Children's Hospitals Network, Sydney, New South Wales, Australia.
Stephen I AlexanderCentre for Kidney Research, Children's Hospital at Westmead, Sydney, New South Wales, Australia.
Steven McTaggartQueensland Child and Adolescent Renal Service, Queensland Children's Hospital, Queensland, Australia.
Jonathan C CraigCollege of Medicine and Public Health, Flinders University, Adelaide, South Australia, Australia.
Carmel M HawleyAustralasian Kidney Trials Network, University of Queensland, Brisbane, Queensland, Australia.
Martin HowellLeeder Centre for Health Policy, Economics and Data, Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia.
NAVKIDS2 Trial Steering Committee2
NAVKIDS Trial Steering Committee

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: The NAVKIDS Methods: Cost and resource utilization data were prospectively collected over 6 months, from a health care funder perspective. Costs were reported in Australian dollars. Quality-of-life (QoL) data were collected from 0 to 6 months. Incremental cost-effectiveness ratios (ICERs) were reported as the additional cost/quality-adjusted life years (QALYs) gained. Results: Over the 6-month period, total per-patient costs were higher in the patient navigation group than in those in the standard care group ($10,249 vs. $9368, respectively; Conclusion: The economic evaluation found that the cost of patient navigators is relatively low compared with total health care costs; however, there is considerable uncertainty regarding the cost-effectiveness of the intervention. Further research is needed to evaluate long-term cost-effectiveness as well as potential impacts on health outcomes and health care utilization.

Indexed as

chronic kidney diseasecostcost-effectivenesseconomic evaluationpatient navigationpediatric nephrology

Identifiers

PMID40980675
PMCPMC12446926

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.